Kopiryna – Tabletki Od Bólu Głowy

Acetylsalicylic acid, the active ingredient in Kopiryna – Tabletki Od Bólu Głowy, is a NSAID presented as a tablet for oral use. It treats headache, migraine, minor pain and fever in adults and adolescents.

GNH USA supplies Kopiryna – Tabletki Od Bólu Głowy as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kopiryna combines acetylsalicylic acid and caffeine to relieve pain and fever by inhibiting prostaglandin synthesis.

- Headache: provides rapid relief of tension‑type and mild migraine headaches. - Fever: reduces elevated body temperature associated with common infections. - Minor pain: alleviates dental, musculoskeletal and other mild pain conditions.

Kopiryna may cause adverse reactions that vary in frequency and severity.

Common Side Effects: - Nausea - Gastric discomfort or heartburn - Increased heart rate - Insomnia or difficulty sleeping - Dizziness - Mild headache

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration - Allergic reactions such as rash, angioedema, or anaphylaxis - Severe liver or kidney impairment - Tinnitus (ringing in the ears) - Asthma exacerbation - Stevens‑Johnson syndrome (very rare)

Before using Kopiryna, consider the following safety measures.

- Use in adults only: not recommended for children under 12 years. - Avoid if known hypersensitivity to aspirin, other NSAIDs, or caffeine. - Caution in patients with peptic ulcer disease, gastrointestinal bleeding, or clotting disorders. - Monitor closely if taking anticoagulants, antiplatelet agents, or other NSAIDs. - Limit alcohol consumption while using this product. - Store at room temperature: keep in the original pack, protect from moisture and direct sunlight.

Kopiryna can interact with several medicines; some require avoidance while others need monitoring.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin, direct oral anticoagulants): increased bleeding risk. - Other NSAIDs or corticosteroids: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding tendency. - Methotrexate: reduced clearance leading to toxicity. - Lithium: increased serum lithium concentrations.

Moderate Interactions (Monitor Closely): - Diuretics: possible alteration of potassium balance. - Antihypertensive agents: caffeine may diminish blood‑pressure‑lowering effect. - Antidiabetic drugs: caffeine may affect glucose control. - Theophylline: additive stimulant effects. - Oral contraceptives: potential increase in clotting risk.